Depression in primary care: interpersonal counseling vs selective serotonin reuptake inhibitors. The DEPICS Study. A multicenter randomized controlled trial. Rationale and design
Marco Menchetti,Biancamaria Bortolotti,Paola Rucci,Paolo Scocco,Annarosa Bombi,Domenico Berardi,DEPICS Study Group,V Affatati,G Alberini,F Baranzini,S Bellino,A Bellomo,T Blasi,F Bogetto,P Bortolaso,C Callegari,B Carpiniello,N Colombini,C Contu,G Croci,M De Salvia,M Diurni,S Elisei,M Ferretti,P Fiore,P Fusar-Poli,S Iuso,A Lacalamita,T La Ferla,L Lia,C C Luciano,M Magnani,D Manganaro,V Martinelli,I Martino,M B Montaguti,C Nespeca,A Petito,F Pinna,M Piselli,P Politi,R Quartesan,A Rella,F Restaino,M Rigatelli,P Sciarini,E Simoni,M Succu,E Tedeschini,O Todarello,S Vender,L Zaccagni,M Zizza
DOI: https://doi.org/10.1186/1471-244X-10-97
IF: 4.144
2010-11-25
BMC Psychiatry
Abstract:Background: Depression is a frequently observed and disabling condition in primary care, mainly treated by Primary Care Physicians with antidepressant drugs. Psychological interventions are recommended as first-line treatment by the most authoritative international guidelines but few evidences are available on their efficacy and effectiveness for mild depression. Methods/design: This multi-center randomized controlled trial was conducted in 9 Italian centres with the aim to compare the efficacy of Inter-Personal Counseling, a brief structured psychological intervention, to that of Selective Serotonin Reuptake Inhibitors. Patients with depressive symptoms referred by Primary Care Physicians to psychiatric consultation-liaison services were eligible for the study if they met the DSM-IV criteria for major depression, had a score ≥ 13 on the 21-item Hamilton Depression Rating Scale, and were at their first or second depressive episode. The primary outcome was remission of depressive symptoms at 2-months, defined as a HDRS score ≤ 7. Secondary outcome measures were improvement in global functioning and recurrence of depressive symptoms at 12-months. Patients who did not respond to Inter-Personal Counseling or Selective Serotonin Reuptake Inhibitors at 2-months received augmentation with the other treatment. Discussion: This trial addresses some of the shortcomings of existing trials targeting major depression in primary care by evaluating the comparative efficacy of a brief psychological intervention that could be easily disseminated, by including a sample of patients with mild/moderate depression and by using different outcome measures. Trial registration: Australian New Zealand Clinical Trials Registry ACTRN12608000479303.